RS54524B1 - Postupak pripreme rastvora levotiroksina - Google Patents

Postupak pripreme rastvora levotiroksina

Info

Publication number
RS54524B1
RS54524B1 RS20150872A RSP20150872A RS54524B1 RS 54524 B1 RS54524 B1 RS 54524B1 RS 20150872 A RS20150872 A RS 20150872A RS P20150872 A RSP20150872 A RS P20150872A RS 54524 B1 RS54524 B1 RS 54524B1
Authority
RS
Serbia
Prior art keywords
levothyroxine
value
sodium
solution
aqueous solvent
Prior art date
Application number
RS20150872A
Other languages
English (en)
Serbian (sr)
Inventor
Yannis PSARRAKIS
Kosta LIOUMIS
Original Assignee
Emp Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44625617&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS54524(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Emp Pharma Gmbh filed Critical Emp Pharma Gmbh
Publication of RS54524B1 publication Critical patent/RS54524B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • A61K31/055Phenols the aromatic ring being substituted by halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RS20150872A 2011-03-10 2011-03-10 Postupak pripreme rastvora levotiroksina RS54524B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11711688.9A EP2683361B2 (en) 2011-03-10 2011-03-10 Method for the preparaton of a levothyroxine solution
PCT/IB2011/051015 WO2012120338A1 (en) 2011-03-10 2011-03-10 Method for the preparaton of a levothyroxine solution

Publications (1)

Publication Number Publication Date
RS54524B1 true RS54524B1 (sr) 2016-06-30

Family

ID=44625617

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20150872A RS54524B1 (sr) 2011-03-10 2011-03-10 Postupak pripreme rastvora levotiroksina

Country Status (12)

Country Link
US (1) US9050307B2 (pl)
EP (1) EP2683361B2 (pl)
CY (1) CY1117151T1 (pl)
DK (1) DK2683361T3 (pl)
ES (1) ES2559818T5 (pl)
HR (1) HRP20151421T1 (pl)
HU (1) HUE028423T2 (pl)
PL (1) PL2683361T5 (pl)
PT (1) PT2683361E (pl)
RS (1) RS54524B1 (pl)
SI (1) SI2683361T1 (pl)
WO (1) WO2012120338A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9345772B1 (en) * 2015-02-27 2016-05-24 Nilesh Parikh Liquid levothyroxine formulations
WO2017077476A1 (en) 2015-11-04 2017-05-11 Leiutis Pharmaceuticals Pvt Ltd Novel levothyroxine formulations for oral use
NL2017110B1 (en) * 2016-07-05 2018-01-12 Emp Levo Gmbh Methods for the preparation of a levothyroxine solution
US20200046664A1 (en) 2016-10-10 2020-02-13 Ftf Pharma Private Limited Method for preparation of liquid oral composition of l-thyroxin
EP3311844A1 (en) * 2016-10-18 2018-04-25 Altergon S.A. High-stability packaged solutions of t4 thyroid hormone
US9782376B1 (en) 2016-12-01 2017-10-10 Fresenius Kabi Usa Llc Levothyroxine liquid formulations
US11241382B2 (en) 2019-03-01 2022-02-08 Altergon Sa Administration regimen of compositions of T4 thyroid hormone with high oral absorption
GR1009815B (el) * 2019-07-25 2020-09-15 Ιουλια Κλεωνος Τσετη Μη αλκοολουχο ελευθερο απο συντηρητικα και καταλληλο για απο του στοματος χορηγηση πολυδοσικο διαλυμα λεβοθυροξινης για την αντιμετωπιση του υποθυρεοειδισμου
US20230338320A1 (en) 2019-11-22 2023-10-26 Wockhardt Limited Oral film composition comprising levothyroxine
EP4704805A2 (en) * 2023-05-02 2026-03-11 Labomed Pharmaceutical Company S.A. Oral solution comprising liothyronine sodium
GR1010807B (el) * 2023-09-15 2024-10-24 Ιουλια Κλεωνος Τσετη Σφραγισμενος μονοδοσικος περιεκτης υδατικου διαλυματος λεβοθυροξινης καταλληλος για απο του στοματος χορηγηση
IT202300020130A1 (it) 2023-09-29 2025-03-29 Ibsa Inst Biochimique Sa Formulazioni farmaceutiche stabili di amminoacidi, peptidi o proteine
CN117919171B (zh) * 2024-03-22 2024-05-31 泊诺(天津)创新医药研究有限公司 一种左甲状腺素钠口服液的制备方法
WO2025253253A1 (en) 2024-06-04 2025-12-11 Ibsa Institut Biochimique Sa Orodispersible solid composition in the form of film for oral administration of thyroid hormones

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3035974A (en) 1960-02-18 1962-05-22 Israel Murray Compositions and method for the parenteral administration of thyroxine
CN1011118B (zh) 1986-06-13 1991-01-09 天津医学院附属医院 治疗白内障的眼药水的制药方法
GB9401891D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US20050059574A1 (en) 2000-12-21 2005-03-17 Irwin Klein Compositions of stable T3 and methodes of use thereof
US20070045951A1 (en) 2003-02-21 2007-03-01 Robertson Phillip J Video game mask
CA2634993A1 (en) 2006-01-06 2007-07-12 Intervet International B.V. Concentrated liquid thyroid hormone composition

Also Published As

Publication number Publication date
CY1117151T1 (el) 2017-04-05
EP2683361A1 (en) 2014-01-15
ES2559818T5 (es) 2024-06-27
PL2683361T5 (pl) 2024-09-09
HUE028423T2 (en) 2016-12-28
US9050307B2 (en) 2015-06-09
EP2683361B2 (en) 2023-11-29
DK2683361T3 (da) 2016-02-01
ES2559818T3 (es) 2016-02-16
US20140073695A1 (en) 2014-03-13
PT2683361E (pt) 2016-02-22
EP2683361B1 (en) 2015-11-25
HRP20151421T1 (hr) 2016-03-25
SI2683361T1 (sl) 2016-02-29
WO2012120338A1 (en) 2012-09-13
PL2683361T3 (pl) 2016-04-29

Similar Documents

Publication Publication Date Title
RS54524B1 (sr) Postupak pripreme rastvora levotiroksina
JP5989095B2 (ja) イブプロフェンの経皮組成物およびその使用方法
US11938109B2 (en) Methods for the preparation of a levothyroxine solution
JP2024050598A (ja) 医薬製剤
EP3513782A1 (en) Gel formulations for oral administration of drugs, in particular to dysphagic patients
EP3261676A2 (en) Liquid levothyroxine formulations
WO2018009761A1 (en) Stabilized liquid formulations containing picosulfate
US11911383B2 (en) Oral solution formulation
CN101455631A (zh) 环磷腺苷葡胺注射液及其制备工艺
WO2019162892A1 (en) Stable injectable compositions of epinephrine
CN112891303A (zh) 一种普瑞巴林口服溶液及其制备方法
CN103126982A (zh) 一种新兽药葡甲胺恩诺沙星注射液及其制备方法
US20200046664A1 (en) Method for preparation of liquid oral composition of l-thyroxin
GB2577363A (en) Liquid pharmaceutical composition for oral administration comprising paracetamol and codeine phosphate
US20070213406A1 (en) Anti-Inflammatory Analgesic External Aqueus Liquid Preparation
WO2009043226A1 (en) A stable liquid composition comprising taxan derivatives and its preparation method.
WO2022038403A1 (ru) Фармацевтическая композиция на основе налбуфина и/или его солей для назального применения
JP7654206B2 (ja) うがい薬の製造方法
BG1842U1 (bg) Фармацевтичен състав на разтвор за перорални капки, съдържащ метамизол
JP2006089415A (ja) カフェイン含有カプセル製剤
DE202011110912U1 (de) Stabile orale Levothyroxin-Lösung
BG1843U1 (bg) Прахообразен фармацевтичен състав, съдържащ метамизол
WO2017091165A1 (en) Liquid formulation of levodropropizine and method for preparation thereof